Cosmos Pharmaceutical Corp
TSE:3349
P/FCFE
Price to FCFE
Price to Free Cash Flow To Equity (P/FCFE) ratio is a valuation multiple that compares a company’s market capitalization to the amount of free cash flow available for equity shareholders. This metric is very similar to the P/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.
Market Cap | P/FCFE | ||||
---|---|---|---|---|---|
JP |
Cosmos Pharmaceutical Corp
TSE:3349
|
514.8B JPY | 79.8 | ||
ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
76.1B Zac | 0 | |
ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
29.3B Zac | 0 | |
US |
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
13.8B USD | -2.4 | ||
BR |
Raia Drogasil SA
BOVESPA:RADL3
|
44.7B BRL | 213.7 | ||
CN |
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
45.8B CNY | 9.4 | ||
JP |
MatsukiyoCocokara & Co
TSE:3088
|
954.8B JPY | 22.7 | ||
MX |
Corporativo Fragua SAB de CV
BMV:FRAGUAB
|
83.1B MXN | 42.9 | ||
SA |
Al Nahdi Medical Company SCJSC
SAU:4164
|
17.5B SAR | 31.9 | ||
CN |
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
23.7B CNY | 10.2 | |
JP |
Sundrug Co Ltd
TSE:9989
|
465B JPY | 144.6 |
P/FCFE Forward Multiples
Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.